Search research articles
Contact Us
Filters
Showing results (331-340 of 453) with videos related to
Page
of 46
Sort By:
Cancer
|
August 10, 2005
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors
J Matthew McDonald, Siew Ju See, Ivo W Tremont, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2017
Novel Targeting of Transcription and Metabolism in Glioblastoma
Yu-Ting Su, Robert Chen, Herui Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 31, 2010
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma
Nadia N Laack, Brian Patrick O'Neill, Karla V Ballman, et al.
Neuro-Oncology
|
December 15, 2010
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
John H Sampson, Kenneth D Aldape, Gary E Archer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study
John F de Groot, Kathleen R Lamborn, Susan M Chang, et al.
Neuro-Oncology Advances
|
October 1, 2025
Characterization of MAIT cells in glioblastoma reveals a potential immunosuppressive role through a MAIT-neutrophil axis
Seketoulie Keretsu, Taijun Hana, Alexander Lee, et al.
Journal of Neuro-Oncology
|
January 25, 2017
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas
Lakshmi Nayak, John de Groot, Jeffrey S Wefel, et al.
Frontiers in Oncology
|
February 6, 2023
Heterogeneous clinicopathological findings and patient-reported outcomes in adults with <i>MN1</i>-altered CNS tumors: A case report and systematic literature review
Stephen C Frederico, Elizabeth Vera, Zied Abdullaev, et al.
Neuro-Oncology Advances
|
February 4, 2022
A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell lines
Ashish H Shah, Robert Suter, Pavan Gudoor, et al.
Neuro-Oncology Practice
|
November 17, 2022
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients
Amanda L King, Dorela D Shuboni-Mulligan, Elizabeth Vera, et al.
Page
of 46
Search research articles
Search
Showing results (331-340 of 453) with videos related to
Sort By:
Page
of 46
Cancer
|
August 10, 2005
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors
J Matthew McDonald, Siew Ju See, Ivo W Tremont, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2017
Novel Targeting of Transcription and Metabolism in Glioblastoma
Yu-Ting Su, Robert Chen, Herui Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 31, 2010
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma
Nadia N Laack, Brian Patrick O'Neill, Karla V Ballman, et al.
Neuro-Oncology
|
December 15, 2010
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
John H Sampson, Kenneth D Aldape, Gary E Archer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study
John F de Groot, Kathleen R Lamborn, Susan M Chang, et al.
Neuro-Oncology Advances
|
October 1, 2025
Characterization of MAIT cells in glioblastoma reveals a potential immunosuppressive role through a MAIT-neutrophil axis
Seketoulie Keretsu, Taijun Hana, Alexander Lee, et al.
Journal of Neuro-Oncology
|
January 25, 2017
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas
Lakshmi Nayak, John de Groot, Jeffrey S Wefel, et al.
Frontiers in Oncology
|
February 6, 2023
Heterogeneous clinicopathological findings and patient-reported outcomes in adults with <i>MN1</i>-altered CNS tumors: A case report and systematic literature review
Stephen C Frederico, Elizabeth Vera, Zied Abdullaev, et al.
Neuro-Oncology Advances
|
February 4, 2022
A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell lines
Ashish H Shah, Robert Suter, Pavan Gudoor, et al.
Neuro-Oncology Practice
|
November 17, 2022
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients
Amanda L King, Dorela D Shuboni-Mulligan, Elizabeth Vera, et al.
Page
of 46